Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas (Q36491117)

14 August 2017

Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas (English)

1 reference

14 August 2017

11

D L Porter

1 reference

14 August 2017

8

A Loren

1 reference

14 August 2017

V R Paralkar

1

1 reference

14 August 2017

S D Nasta

2

1 reference

14 August 2017

K Morrissey

3

1 reference

14 August 2017

J Smith

4

1 reference

14 August 2017

P Vassilev

5

1 reference

14 August 2017

M E Martin

6

1 reference

14 August 2017

S C Goldstein

7

1 reference

14 August 2017

A H Rook

9

1 reference

14 August 2017

E J Kim

10

1 reference

14 August 2017

language of work or name

English

0 references

publication date

24 October 2011

1 reference

Bone Marrow Transplantation

14 August 2017

1 reference

14 August 2017

47

1 reference

14 August 2017

7

1 reference

14 August 2017

940-945

1 reference

Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine-melphalan conditioning for treatment of mature T-cell lymphomas

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3531042

Targeting histone deacetyalses in the treatment of B- and T-cell malignancies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3531042

Allogeneic immunotherapy to optimize the graft-versus-tumor effect: concepts and controversies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3531042

Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3531042

Cutaneous T-cell lymphoma: Biologic targets for therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3531042

New targets of therapy in T-cell lymphomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3531042

Current and emerging treatment strategies for cutaneous T-cell lymphoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3531042

Update on treatment of cutaneous T-cell lymphoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3531042

Novel therapies for cutaneous T-cell lymphomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3531042

Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3531042

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3531042

Cytokine therapy of cutaneous T-cell lymphoma: interferons, interleukin-12, and interleukin-2.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3531042

Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3531042

Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3531042

Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3531042

Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3531042

Nonparametric Estimation from Incomplete Observations

21 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBMT.2011.201

Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients

21 January 2018

1 reference

12 December 2020

Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features

1 reference

12 December 2020

Phase III placebo-controlled trial of denileukin diftitox for patients with cutaneous T-cell lymphoma

1 reference

12 December 2020

Autologous bone marrow transplantation for advanced stage mycosis fungoides

1 reference

12 December 2020

Identifiers

DOI

10.1038/BMT.2011.201

1 reference

release_gqsw5woaerb5pilj7hrgrl4dne

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gqsw5woaerb5pilj7hrgrl4dne

24 November 2022

mapped directly with Wikidata item

1 reference

14 August 2017

PubMed publication ID

22020023

1 reference